Literature DB >> 23046516

Maintenance of adult cardiac function requires the chromatin factor Asxl2.

Hsiao-Lei Lai1, Milana Grachoff, Andrea L McGinley, Farida F Khan, Chad M Warren, Shamim A K Chowdhury, Beata M Wolska, R John Solaro, David L Geenen, Q Tian Wang.   

Abstract

During development and differentiation, cell type-specific chromatin configurations are set up to facilitate cell type-specific gene expression. Defects in the establishment or the maintenance of the correct chromatin configuration have been associated with diseases ranging from leukemia to muscular dystrophy. The heart expresses many chromatin factors, and we are only beginning to understand their roles in heart development and function. We have previously shown that the chromatin regulator Asxl2 is highly expressed in the murine heart both during development and adulthood. In the absence of Asxl2, there is a significant reduction in trimethylation of histone H3 lysine 27 (H3K27), a histone mark associated with lineage-specific silencing of developmental genes. Here we present evidence that Asxl2 is required for the long-term maintenance of ventricular function and for the maintenance of normal cardiac gene expression. Asxl2(-/-) hearts displayed progressive deterioration of ventricular function. By 10 months of age, there was ~37% reduction in fractional shortening in Asxl2(-/-) hearts compared to wild-type. Analysis of the expression of myofibril proteins suggests that Asxl2 is required for the repression of β-MHC. Asxl2(-/-) hearts did not exhibit hypertrophy, suggesting that the de-repression of β-MHC was not the result of hypertrophic response. Instead, Asxl2 and the histone methyltansferase Ezh2 co-localize to β-MHC promoter, suggesting that Asxl2 directly represses β-MHC. Interrogation of the CardioGenomics database revealed that ASXL2 is down-regulated in the hearts of patients with ischemic or idiopathic dilated cardiomyopathy. We propose that chromatin factors like Asxl2 function in the adult heart to regulate cell type- and stage-specific patterns of gene expression, and the disruption of such regulation may be involved in the etiology and/or development of certain forms of human heart disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046516      PMCID: PMC3472135          DOI: 10.1016/j.yjmcc.2012.08.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  33 in total

Review 1.  Polycomb silencing mechanisms and the management of genomic programmes.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

Review 2.  Polycomb/Trithorax response elements and epigenetic memory of cell identity.

Authors:  Leonie Ringrose; Renato Paro
Journal:  Development       Date:  2007-01       Impact factor: 6.868

Review 3.  Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms.

Authors:  Pathik D Wadhwa; Claudia Buss; Sonja Entringer; James M Swanson
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

4.  Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that regulates transcription and reexpression of a protective fetal program.

Authors:  Esta Bovill; Stephen Westaby; Shiney Reji; Rana Sayeed; Alastair Crisp; Tony Shaw
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-09       Impact factor: 5.209

Review 5.  Methods in cardiomyocyte isolation, culture, and gene transfer.

Authors:  William E Louch; Katherine A Sheehan; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2011-06-24       Impact factor: 5.000

6.  Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.

Authors:  Johanna C Scheuermann; Andrés Gaytán de Ayala Alonso; Katarzyna Oktaba; Nga Ly-Hartig; Robert K McGinty; Sven Fraterman; Matthias Wilm; Tom W Muir; Jürg Müller
Journal:  Nature       Date:  2010-05-02       Impact factor: 49.962

7.  Why does troponin I have so many phosphorylation sites? Fact and fancy.

Authors:  R John Solaro; Jolanda van der Velden
Journal:  J Mol Cell Cardiol       Date:  2010-02-25       Impact factor: 5.000

8.  Chromatin regulation by Brg1 underlies heart muscle development and disease.

Authors:  Calvin T Hang; Jin Yang; Pei Han; Hsiu-Ling Cheng; Ching Shang; Euan Ashley; Bin Zhou; Ching-Pin Chang
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

9.  Chromatin remodelling complex dosage modulates transcription factor function in heart development.

Authors:  Jun K Takeuchi; Xin Lou; Jeffrey M Alexander; Hiroe Sugizaki; Paul Delgado-Olguín; Alisha K Holloway; Alessandro D Mori; John N Wylie; Chantilly Munson; Yonghong Zhu; Yu-Qing Zhou; Ru-Fang Yeh; R Mark Henkelman; Richard P Harvey; Daniel Metzger; Pierre Chambon; Didier Y R Stainier; Katherine S Pollard; Ian C Scott; Benoit G Bruneau
Journal:  Nat Commun       Date:  2011-02-08       Impact factor: 14.919

10.  Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx.

Authors:  Heather A Baskind; Lucy Na; Quanhong Ma; Mayur P Patel; David L Geenen; Q Tian Wang
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

View more
  13 in total

Review 1.  Interplay of chromatin modifications and non-coding RNAs in the heart.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2013-10-10       Impact factor: 4.528

2.  De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.

Authors:  Vandana Shashi; Loren D M Pena; Katherine Kim; Barbara Burton; Maja Hempel; Kelly Schoch; Magdalena Walkiewicz; Heather M McLaughlin; Megan Cho; Nicholas Stong; Scott E Hickey; Christine M Shuss; Michael S Freemark; Jane S Bellet; Martha Ann Keels; Melanie J Bonner; Maysantoine El-Dairi; Megan Butler; Peter G Kranz; Constance T R M Stumpel; Sylvia Klinkenberg; Karin Oberndorff; Malik Alawi; Rene Santer; Slavé Petrovski; Outi Kuismin; Satu Korpi-Heikkilä; Olli Pietilainen; Palotie Aarno; Mitja I Kurki; Alexander Hoischen; Anna C Need; David B Goldstein; Fanny Kortüm
Journal:  Am J Hum Genet       Date:  2016-09-29       Impact factor: 11.025

Review 3.  The Role of Additional Sex Combs-Like Proteins in Cancer.

Authors:  Jean-Baptiste Micol; Omar Abdel-Wahab
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  Compound heterozygous mutation of the ASXL3 gene causes autosomal recessive congenital heart disease.

Authors:  Fang Fu; Ru Li; Ting-Ying Lei; Dan Wang; Xin Yang; Jin Han; Min Pan; Li Zhen; Jian Li; Fa-Tao Li; Xiang-Yi Jing; Dong-Zhi Li; Can Liao
Journal:  Hum Genet       Date:  2020-07-21       Impact factor: 4.132

5.  ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

Authors:  U-H Park; M-R Kang; E-J Kim; Y-S Kwon; W Hur; S K Yoon; B-J Song; J H Park; J-T Hwang; J-C Jeong; S-J Um
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

6.  Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis.

Authors:  Christopher A Koczor; Eva K Lee; Rebecca A Torres; Amy Boyd; J David Vega; Karan Uppal; Fan Yuan; Earl J Fields; Allen M Samarel; William Lewis
Journal:  Physiol Genomics       Date:  2013-05-21       Impact factor: 3.107

7.  Loss of Asxl2 leads to myeloid malignancies in mice.

Authors:  Jianping Li; Fuhong He; Peng Zhang; Shi Chen; Hui Shi; Yanling Sun; Ying Guo; Hui Yang; Na Man; Sarah Greenblatt; Zhaomin Li; Zhengyu Guo; Yuan Zhou; Lan Wang; Lluis Morey; Sion Williams; Xi Chen; Qun-Tian Wang; Stephen D Nimer; Peng Yu; Qian-Fei Wang; Mingjiang Xu; Feng-Chun Yang
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

8.  ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion.

Authors:  Vikas Madan; Lin Han; Norimichi Hattori; Weoi Woon Teoh; Anand Mayakonda; Qiao-Yang Sun; Ling-Wen Ding; Hazimah Binte Mohd Nordin; Su Lin Lim; Pavithra Shyamsunder; Pushkar Dakle; Janani Sundaresan; Ngan B Doan; Masashi Sanada; Aiko Sato-Otsubo; Manja Meggendorfer; Henry Yang; Jonathan W Said; Seishi Ogawa; Torsten Haferlach; Der-Cherng Liang; Lee-Yung Shih; Tsuyoshi Nakamaki; Q Tian Wang; H Phillip Koeffler
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

9.  Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets.

Authors:  Hsiao-Lei Lai; Q Tian Wang
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Asxl2-/- Mice Exhibit De Novo Cardiomyocyte Production during Adulthood.

Authors:  Rachel Brunner; Hsiao-Lei Lai; Zane Deliu; Elan Melman; David L Geenen; Q Tian Wang
Journal:  J Dev Biol       Date:  2016-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.